» Articles » PMID: 18655988

Effect of a New Cohesive Ophthalmic Viscosurgical Device on Corneal Protection and Intraocular Pressure in Small-incision Cataract Surgery

Overview
Specialty Ophthalmology
Date 2008 Jul 29
PMID 18655988
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the corneal protective and intraocular pressure (IOP) effects of a new cohesive ophthalmic viscosurgical (OVD), Neocrom Cohesive (sodium hyaluronate 1.4%), with those of Healon (sodium hyaluronate 1.0%) in cataract surgery.

Setting: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.

Methods: This randomized patient-masked examiner-masked study with fellow-eye comparison comprised 29 cataract surgery patients. Surgery was performed with Neocrom Cohesive in 1 eye and Healon in the other eye. Central corneal thickness (CCT) was measured preoperatively and 1 day and 3 months postoperatively; endothelial cell density (ECD), preoperatively and 3 months postoperatively; and IOP, preoperatively and 6 hours and 1 day postoperatively.

Results: The mean CCT change from preoperatively to postoperatively in the Neocrom Cohesive, respectively, group and Healon group was +16.0 microm +/- 25.7 (SD) (P<.01) and +7.0 +/- 17.1 microm (P<.05), respectively, at 1 day and -5.7 +/- 10.8 microm (P<.01) and -4.7 microm +/- 9.5 microm) (P<.01), respectively, at 3 months. The mean ECD change at 3 months was 8 +/- 155 cells/mm(2) in the Neocrom Cohesive group (P = .8) and -46 +/- 139 cells/mm(2) in the Healon group (P = .08). The mean IOP increase was +2.2 +/- 3.5 mm Hg (P<.01) and +1.4 +/- 4.2 mm Hg (P = .14), respectively, 6 hours postoperatively and +0.9 +/- 4.3 mm Hg (P = .37) and 0.0 +/- 3.5 mm Hg (P = .77), respectively, at 1 day.

Conclusion: There was no significant difference between Neocrom Cohesive and Healon in the changes in CCT, ECD, and IOP after cataract surgery.

Citing Articles

Thickness of the Protective Layers of Different Ophthalmic Viscosurgical Devices During Lens Surgery in a Porcine Model.

Wust M, Matten P, Nenning M, Findl O Transl Vis Sci Technol. 2022; 11(2):28.

PMID: 35175318 PMC: 8857612. DOI: 10.1167/tvst.11.2.28.


Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery.

Malvankar-Mehta M, Fu A, Subramanian Y, Hutnik C J Ophthalmol. 2020; 2020:7801093.

PMID: 33133677 PMC: 7593745. DOI: 10.1155/2020/7801093.


Hyaluronic Acid: Redefining Its Role.

Abatangelo G, Vindigni V, Avruscio G, Pandis L, Brun P Cells. 2020; 9(7).

PMID: 32708202 PMC: 7409253. DOI: 10.3390/cells9071743.


Hyaluronic Acid-Cellulose Composites as Patches for Minimizing Bacterial Infections.

Lopez K, Ravula S, Perez R, Ayala C, Losso J, Janes M ACS Omega. 2020; 5(8):4125-4132.

PMID: 32149241 PMC: 7057694. DOI: 10.1021/acsomega.9b03852.


Hyaluronic Acid in the Third Millennium.

Fallacara A, Baldini E, Manfredini S, Vertuani S Polymers (Basel). 2019; 10(7).

PMID: 30960626 PMC: 6403654. DOI: 10.3390/polym10070701.